ARCHIVES

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

This article is from The Cancer Letter archive.

Vol. 04 No. 15 | April 14, 1978

Download PDF Visit The Full Archive

Related Articles

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

Abstracts From AACR Annual Meeting

May 21, 1976

NCI Advisors Approve Research Network On Screening

August 6, 2010

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014